PharVision Advisers’s WesBanco WSBC Stock Holding History

PharVision Advisers’s Portfolio WSBC Stock Details WSBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,530	Closed	-$375K	–	534
2024 Q4	$375K	Buy	+11,530	New	+$382K	0.32%	90

Other funds holding WSBC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

PharVision Advisers's WSBC Position: Q1 2025 in Review

PharVision Advisers sold out of WesBanco (WSBC) in Q1 2025, closing a stake of 11,530 shares — an estimated $375K sold.

PharVision Advisers first reported a position in WSBC in Q4 2024 and held it in 1 quarter. The position peaked at $375K in Q4 2024. 311 funds tracked by Wall St. Rank hold WSBC as of Q1 2025.

PharVision Advisers reported no remaining WesBanco position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 11,530 WesBanco shares in Q1 2025, an estimated $375K.
PharVision Advisers first reported a position in WesBanco in Q4 2024 and held it in 1 quarter.
PharVision Advisers's WesBanco position peaked at $375K in Q4 2024.
311 funds tracked by Wall St. Rank held WesBanco as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.